Talib W, Mahmod A, Abuarab S, Hasen E, Munaim A, Haif S
Molecules. 2021; 26(8).
PMID: 33920079
PMC: 8070467.
DOI: 10.3390/molecules26082179.
Mobasher M, Germoush M, Galal El-Tantawi H, El-Said K
Pathogens. 2021; 10(1).
PMID: 33440701
PMC: 7830090.
DOI: 10.3390/pathogens10010059.
Wang G, Xu M, Xie M
Zhongguo Fei Ai Za Zhi. 2020; 23(4):282-285.
PMID: 32316716
PMC: 7210087.
DOI: 10.3779/j.issn.1009-3419.2020.102.02.
Wynn A, Vacheron A, Zuber J, Solomon S
Am J Med Sci. 2019; 358(3):200-203.
PMID: 31324361
PMC: 6708761.
DOI: 10.1016/j.amjms.2019.06.002.
Bonanno L, Zulato E, Pavan A, Attili I, Pasello G, Conte P
Int J Mol Sci. 2019; 20(8).
PMID: 30995715
PMC: 6514929.
DOI: 10.3390/ijms20081874.
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.
Nilsson M, Sun H, Diao L, Tong P, Liu D, Li L
Sci Transl Med. 2017; 9(415).
PMID: 29118262
PMC: 5870120.
DOI: 10.1126/scitranslmed.aao4307.
Metformin targets multiple signaling pathways in cancer.
Lei Y, Yi Y, Liu Y, Liu X, Keller E, Qian C
Chin J Cancer. 2017; 36(1):17.
PMID: 28126011
PMC: 5270304.
DOI: 10.1186/s40880-017-0184-9.
Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?.
Heidari F, Abbas Zade S, Mir Hosseini S, Ghadian A
Nephrourol Mon. 2016; 8(3):e30261.
PMID: 27570750
PMC: 4983155.
DOI: 10.5812/numonthly.30261.
Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.
Jo W, Yu E, Chang M, Park H, Choi H, Ryu J
Mol Med Rep. 2015; 13(1):146-52.
PMID: 26548419
PMC: 4686101.
DOI: 10.3892/mmr.2015.4513.
PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Chen Z, Zhao W, Qu S, Li L, Lu X, Su F
Mol Med Rep. 2015; 12(2):1868-76.
PMID: 25872765
PMC: 4463980.
DOI: 10.3892/mmr.2015.3604.
Reduction behavior induced by HL010183, a metformin derivative against the growth of cutaneous squamous cell carcinoma.
Miao G, Liu B, Guo X, Zhang X, Liu G
Int J Clin Exp Pathol. 2015; 8(1):287-97.
PMID: 25755715
PMC: 4348908.
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.
Muc-Wierzgon M, Nowakowska-Zajdel E, Dziegielewska-Gesiak S, Kokot T, Klakla K, Fatyga E
World J Gastroenterol. 2014; 20(29):9759-74.
PMID: 25110413
PMC: 4123364.
DOI: 10.3748/wjg.v20.i29.9759.
Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.
Perez-Revuelta B, Hettich M, Ciociaro A, Rotermund C, Kahle P, Krauss S
Cell Death Dis. 2014; 5:e1209.
PMID: 24810045
PMC: 4047877.
DOI: 10.1038/cddis.2014.175.
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.
Wurth R, Barbieri F, Florio T
Biomed Res Int. 2014; 2014:126586.
PMID: 24527434
PMC: 3909978.
DOI: 10.1155/2014/126586.
Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
Xiao X, He Q, Lu C, Werle K, Zhao R, Chen J
Gynecol Oncol. 2012; 127(1):249-55.
PMID: 22735790
PMC: 3432698.
DOI: 10.1016/j.ygyno.2012.06.032.
Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.
Bhalla K, Hwang B, Dewi R, Twaddel W, Goloubeva O, Wong K
Cancer Prev Res (Phila). 2012; 5(4):544-52.
PMID: 22467080
PMC: 3324649.
DOI: 10.1158/1940-6207.CAPR-11-0228.
Metformin: multi-faceted protection against cancer.
Del Barco S, Vazquez-Martin A, Cufi S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J
Oncotarget. 2011; 2(12):896-917.
PMID: 22203527
PMC: 3282095.
DOI: 10.18632/oncotarget.387.
Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator.
Lee K, Hsu E, Guh J, Yang H, Wang D, Kulp S
J Biol Chem. 2011; 286(45):39247-58.
PMID: 21917926
PMC: 3234749.
DOI: 10.1074/jbc.M111.264598.
The BATTLE to personalize lung cancer prevention through reverse migration.
Gold K, Kim E, Lee J, Wistuba I, Farhangfar C, Hong W
Cancer Prev Res (Phila). 2011; 4(7):962-72.
PMID: 21733820
PMC: 3171137.
DOI: 10.1158/1940-6207.CAPR-11-0232.
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.
Vazquez-Martin A, Lopez-Bonetc E, Cufi S, Oliveras-Ferraros C, Del Barco S, Martin-Castillo B
Drug Resist Updat. 2011; 14(4-5):212-23.
PMID: 21600837
PMC: 3742095.
DOI: 10.1016/j.drup.2011.04.003.
